M Takada

CPT-11 in combination with cisplatin for advanced non-small-cell lung cancer.

N Masuda, M. Fukuoka, M Takada et al. · Journal of Clinical Oncology · 1992 · 141 citations

Second primary tumours in more than 2-year disease-free survivors of small-cell lung cancer in Japan: the role of smoking cessation

Mutsuto Kawahara, Shinichiro Ushijima, Takao Kamimori et al. · British Journal of Cancer · 1998 · 130 citations · Full text

Tobacco Control, 2-Year Disease-free Survivors, Medicine +10

Role of radiotherapy in combined modality treatment of locally advanced non-small-cell lung cancer.

Kaoru Kubota, Kiyoyuki Furuse, Mutsuto Kawahara et al. · Journal of Clinical Oncology · 1994 · 85 citations

Measurement of cytokeratin 19 fragments as a marker of lung cancer by CYFRA 21-1 enzyme immunoassay

M Takada, N Masuda, Eiji Matsuura et al. · British Journal of Cancer · 1995 · 77 citations · Full text

Cyfra 21-1 Enzyme, Cytokeratin 19, Medicine +8

A randomized trial in inoperable non-small-cell lung cancer: vindesine and cisplatin versus mitomycin, vindesine, and cisplatin versus etoposide and cisplatin alternating with vindesine and mitomycin.

M. Fukuoka, N Masuda, Kiyoyuki Furuse et al. · Journal of Clinical Oncology · 1991 · 69 citations

Pharmacotherapy, Metronomic Chemotherapy, Cisplatin Versus Etoposide +17